文献速递乳腺癌

法国多中心队列:pN0-1mi乳腺癌术后放疗价值探讨

Is post-mastectomy radiation therapy contributive in pN0-1mi breast cancer patients? Results of a French multi-centric cohort.
PubMed 文献 · Eur J Cancer · 2017-11-03

该研究回顾性分析法国多中心4283例1980-2013年接受乳房切除与腋窝清扫的乳腺癌患者,评估术后放疗(PMRT)在pN0-1mi人群中的价值。多因素分析显示PMRT对无局部区域复发生存和DFS有接近显著的改善,但未能识别出可从PMRT获益的亚组,c-PMRT指数亦未能辅助决策。

要点

  • pN0-1mi患者中超过半数接受PMRT,对LRR-free生存和DFS改善接近显著。
  • 按临床病理复发风险因素数量匹配后,≥3个风险因素亚组未显示PMRT获益。
  • c-PMRT指数可预测结局,但未能帮助决定是否使用PMRT。

核心结论

  • 尽管研究大样本队列,未能隔离出适合PMRT的无淋巴结受累早期乳腺癌亚组。

研究设计与样本

  • 法国多中心回顾性队列,纳入1980至2013年间接受乳房切除和腋窝清扫的4283例患者,分析三个治疗时期(1980-1999、2000-2005、2006-2013)的实践。

主要发现

  • pN0-1mi患者中超过半数接受PMRT,PMRT对无局部区域复发生存和DFS的改善接近显著。
  • 基于临床病理复发风险因素数量匹配pN0-1mi患者,识别出≥3个复发风险因素的高危亚群,但PMRT未改善该亚组结局。
  • c-PMRT指数有预测患者结局的潜力,但其使用未能帮助决定是否采用PMRT。

关键数值与推荐

  • pN0-1mi患者中超过半数接受PMRT;PMRT对LRR-free生存和DFS改善接近显著。
  • ≥3个复发风险因素亚组未从PMRT获益。

临床怎么用

  • 对于pN0-1mi乳腺癌患者,PMRT的决策仍需个体化,现有预后指数未能明确筛选获益人群。

局限性

  • 回顾性多中心队列设计,治疗实践跨越多个时期,可能存在选择偏倚和混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To assess the value of post-mastectomy radiation therapy (PMRT) to breast cancer (BC) patients with no or minimal lymph node (LN) involvement. MATERIALS AND METHODS: We retrospectively analysed a French multi-centric cohort of 4283 patients treated by mastectomy and axillary dissection, with or without PMRT, between 1980 and 2013. Practices were analysed for three treatment periods (1980-1999, 2000-2005 and 2006-2013). The impact of PMRT on loco-regional recurrence (LRR), disease-free survival (DFS), BC-specific survival and overall survival was assessed in pN0-1mi patients using multivariate analyses (logistic regression and Cox model). It was subsequently assessed based on the number of clinicopathological recurrence-risk factors, generating a prognostic index (French-PMRT index), to isolate a pN0-1mi patients subgroup that might derive a benefit from PMRT. We tested the accuracy of the Cambridge-PMRT (c-PMRT) index to discriminate between patients with significantly different outcomes and the value of PMRT in each c-PMRT prognostic group. RESULTS: More than half of the pN0-1mi patients of our cohort underwent PMRT, which almost significantly improved LRR-free survival and DFS. Matching pN0-1mi patients based on the number of clinicopathologic recurrence-risk factors identified a higher risk subpopulation (≥3 recurrence-risk factors), but PMRT did not improve patient outcomes. Although the c-PMRT index had the potential to predict patient outcomes, its use did not help in making the decision of whether or not to use PMRT. CONCLUSION: We failed to isolate a subgroup of early BC patients without LN involvement suitable for PMRT, despite studying a large cohort.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Forissier V, Tallet A, Cohen M, et al. Is post-mastectomy radiation therapy contributive in pN0-1mi breast cancer patients? Results of a French multi-centric cohort. Eur J Cancer. 2017. PMID: 29107861. doi:10.1016/j.ejca.2017.10.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。